Annual Shareholders Equity
$257.65 M
+$410.85 M+268.19%
December 31, 2024
Summary
- As of March 12, 2025, AVBP annual stockholders equity is $257.65 million, with the most recent change of +$410.85 million (+268.19%) on December 31, 2024.
- During the last 3 years, AVBP annual shareholders equity has risen by +$216.43 million (+525.06%).
- AVBP annual shareholders equity is now at all-time high.
Performance
AVBP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$257.65 M
+$410.85 M+268.19%
December 31, 2024
Summary
- As of March 12, 2025, AVBP quarterly stockholders equity is $257.65 million, with the most recent change of +$410.85 million (+268.19%) on December 31, 2024.
- Over the past year, AVBP quarterly shareholders equity has dropped by -$39.01 million (-13.15%).
- AVBP quarterly shareholders equity is now -18.91% below its all-time high of $317.72 million, reached on March 31, 2024.
Performance
AVBP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AVBP Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +268.2% | -13.2% |
| 3 y3 years | +525.1% | -13.2% |
| 5 y5 years | +525.1% | -13.2% |
AVBP Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +268.2% | -18.9% | +268.2% |
| 5 y | 5-year | at high | +268.2% | -18.9% | +268.2% |
| alltime | all time | at high | +268.2% | -18.9% | +268.2% |
ArriVent BioPharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $257.65 M(-268.2%) | $257.65 M(-268.2%) |
| Sep 2024 | - | -$153.19 M(-151.6%) |
| Jun 2024 | - | $296.66 M(-6.6%) |
| Mar 2024 | - | $317.72 M(-307.4%) |
| Dec 2023 | -$153.19 M | -$153.19 M(+15.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$132.60 M(-171.3%) |
| Jun 2023 | - | $186.03 M(-318.6%) |
| Dec 2022 | -$85.11 M(-306.5%) | - |
| Dec 2022 | - | -$85.11 M |
| Dec 2021 | $41.22 M | - |
FAQ
- What is ArriVent BioPharma annual stockholders equity?
- What is the all time high annual shareholders equity for ArriVent BioPharma?
- What is ArriVent BioPharma annual shareholders equity year-on-year change?
- What is ArriVent BioPharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly shareholders equity year-on-year change?
What is ArriVent BioPharma annual stockholders equity?
The current annual shareholders equity of AVBP is $257.65 M
What is the all time high annual shareholders equity for ArriVent BioPharma?
ArriVent BioPharma all-time high annual stockholders equity is $257.65 M
What is ArriVent BioPharma annual shareholders equity year-on-year change?
Over the past year, AVBP annual stockholders equity has changed by +$410.85 M (+268.19%)
What is ArriVent BioPharma quarterly stockholders equity?
The current quarterly shareholders equity of AVBP is $257.65 M
What is the all time high quarterly shareholders equity for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly stockholders equity is $317.72 M
What is ArriVent BioPharma quarterly shareholders equity year-on-year change?
Over the past year, AVBP quarterly stockholders equity has changed by -$39.01 M (-13.15%)